Next Article in Journal
Examining the Contribution of Nurse Practitioners to Geriatric and Palliative Care in Israel
Next Article in Special Issue
Prolonged Hospital Stay in Hypertensive Patients: Retrospective Analysis of Risk Factors and Interactions
Previous Article in Journal
Assessment of Maternal Dietary Intake, Physical Activity Status, and Body Composition During Pregnancy: A Cross-Sectional Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Relationship Between Frailty and Risk of Falls Among Hospitalised Older People with Cardiac Conditions: An Observational Cohort Study

by
Noel Rivas-González
1,
María López
2,3,*,
Belén Martín-Gil
4,
Mercedes Fernández-Castro
5,
María José Castro
2,3 and
J. Alberto San Román
6,7
1
Continuing Education Department, Valladolid University Clinical Hospital, 47005 Valladolid, Spain
2
Faculty of Nursing, University of Valladolid, 47003 Valladolid, Spain
3
GIR Research Group on Multidisciplinary Assessment and Intervention in Health Care and Sustainable Lifestyles, University of Valladolid, 47003 Valladolid, Spain
4
Department of Nursing Care Information Systems, Valladolid University Clinical Hospital, 47005 Valladolid, Spain
5
Research Support Unit, Valladolid University Clinical Hospital, 47005 Valladolid, Spain
6
Cardiology Department, Valladolid University Clinical Hospital, 47005 Valladolid, Spain
7
Centro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain
*
Author to whom correspondence should be addressed.
Nurs. Rep. 2025, 15(3), 100; https://doi.org/10.3390/nursrep15030100
Submission received: 27 December 2024 / Revised: 10 March 2025 / Accepted: 13 March 2025 / Published: 15 March 2025
(This article belongs to the Special Issue Innovations and Challenges in Cardiovascular Nursing)

Abstract

:
Background/Objective: Ageing favours the onset of cardiovascular diseases, frailty, and risk of falls. In the hospital setting, 47.7% of patients may be frail, and the incidence of falls may be as high as five per thousand. This study seeks to determine the relationship between frailty, risk of falls, and length of hospital stays in hospitalised older adults with heart disease. Methods: An observational study was conducted of a cohort of patients aged ≥60 years admitted to a cardiology unit (2022–2024). Frailty was assessed using Fried’s phenotype, risk of falls using the J.H. Downton scale, and level of dependency using the Barthel index. Clinical variables, anthropometric measurements, and length of stay were analysed. Statistical analysis: quantitative variables were expressed as means and standard deviations, and categorical variables as frequencies. Associations were analysed using Student’s t-tests, chi-squared tests, and Kruskal–Wallis tests for comparisons of three or more groups. Relationships between frailty, risk of falls, and other variables were examined using univariate binary logistic regression, with a 95% confidence interval and statistical significance set at p < 0.05. Results: A total of 144 patients were recruited (mean age = 73.08 years [SD = 7.95]) (women = 33.30%). Frailty was associated with waist circumference in men (p = 0.01) and diastolic blood pressure in women (p = 0.05). Frailty was further linked to Downton scores (odds ratio [OR] = 1.565; 95% CI: 1.156–2.120; p = 0.004), age (OR = 1.114; 95% CI: 1.058–1.173; p = 0.000), Barthel index (OR = 0.902; 95% CI: 0.854–0.953; p = 0.000), and length of stay (OR = 1.101; 95% CI: 1.021–1.186; p = 0.012). Conclusions: Frailty appears to be related to Downton scores and impacts the length of hospital stays in older adults hospitalised with cardiac conditions.

1. Introduction

Frailty syndrome, cardiovascular diseases (CVDs), and falls are three of the most prevalent health issues among older adults [1], with significantly different outcomes between sexes [2,3,4].
The ageing process begins at 60 years of age, a stage marked by declining physical condition and an increased risk of disease. Globally, the number of people aged 60 and above reached 1 billion in 2019 and is projected to rise to 2.5 billion by 2050 [5].
CVDs are one of the most common conditions worldwide during this period, directly linked to morbidity, disability, and mortality [6]. The risk of CVD is particularly elevated among women due to the physiological changes associated with menopause [7,8].
In later life, an imbalance in homeostasis can lead to the emergence of frailty syndrome, first defined by Linda Fried et al. as a physical phenotype in 2001. Various tools for identifying frailty exist in the literature, with Fried’s five-criteria scale being among the most widely used [9].
Frailty has been associated with adverse outcomes such as increased risk of hospitalisation, falls, and mortality, all of which lead to higher healthcare costs [10].
Ongoing research into defining frailty and developing tools to address its multifactorial nature reveals varying prevalence rates depending on the study setting. Doody et al. (2023) reported a frailty prevalence of 10.7% among community-dwelling older adults, compared to 47.4% among hospitalised older patients [1]. Despite having a longer life expectancy, women are more frequently affected by frailty [2], with a prevalence of 9.6% compared to 5.4% in men [11].
Xu, Ou, and Li provided evidence that CVD, frailty, and hypertension increase the risk of falls [12]. Similarly, a study in the United Kingdom found that pre-frail and frail patients had a 47% and 15% higher risk of developing CVD, respectively, compared to non-frail patients [13]. Atrial fibrillation is the most common type of cardiac arrhythmia in older adults, with the incidence estimated to increase progressively from the age of 50 in men and 60 in women [14]. Atrial fibrillation in hospitalised patients has been strongly associated with frailty (OR = 4.09, 95%CI: 1.51–11.07) [15].
Other researchers have linked CVD to an elevated risk of mortality (relative risk [RR] = 1.81; 95% CI: 1.67–1.97) among fall-related incidents, with age being a contributing factor [16,17].
The multifactorial concept of frailty has led to the identification of associated factors such as advanced age, polypharmacy, or female sex, among others. In the same way, comorbidities have been identified that can increase the risk of presenting with frailty. Similarly, comorbidities that may increase the risk of frailty have been identified, such as diabetes or previous falls [18].
Falls compromise personal safety and are more common among older adults [19], with a higher prevalence among women [20]. In hospital settings, falls are the most frequent adverse event, with an incidence of 3–5 falls per 1000 patient-days and an estimated annual occurrence of 700,000 to 1 million cases [21,22].
Preventing falls has been a key area of study. Multifactorial programmes such as 6-PACK and Best Practice Spotlight Organisations (BPSO®) include guidelines like the Prevention of Falls and Fall Injuries Best Practice Guideline [23,24]. A common recommendation across these programmes is to identify patients at risk of falling so as to implement targeted interventions [25,26].
The region of Castile & León in Spain is a geographical area with demographic indicators that reflect an ageing, a longevity, and a dependency higher than the rest of the Spanish population, which conditions its service strategy in relation to dependency, multiple pathology, and chronicity.
The interplay between CVD, frailty, and falls poses a significant challenge to therapeutic actions for these patients. These challenges are further influenced by sex differences and the traditional threshold for ageing being set at 65 years, even though physiological changes begin at 60 years. Addressing these factors could have a profound impact on population health and the economic resources of healthcare systems. For these reasons, this study aimed to analyse the relationship between frailty, risk of falls, and length of hospital stay in hospitalised older adults with cardiac conditions.

2. Materials and Methods

2.1. Study Design, Setting, and Sampling

An observational pilot cohort study was conducted in a tertiary hospital within the public network of the Spanish National Health System. Recruitment took place between March 2022 and September 2024, involving patients admitted to a conventional cardiology hospitalisation unit. Individuals aged ≥60 years who were conscious and oriented were included. Patients with cognitive impairment, admission of less than 48 h, bed rest, or where not all the data required for the study could not be collected were excluded from the study.
The study is reported according to STROBE reporting guidelines for observational research.
The study participants were selected using a non-probabilistic convenience sampling method in the cardiology unit. Patients were recruited as they were consecutively admitted to the unit.

2.2. Instruments

2.2.1. Fall Risk Assessment

Fall risk screening was conducted using the BPSO® programme, introduced in Spain in 2010 through the Carlos III Health Institute under the Ministry of Science, Innovation, and Universities. The programme was implemented in the study hospital in 2018, with the Prevention of Falls and Fall Injuries guideline being adopted in 2019. Fall risk was evaluated using the J.H. Downton scale, which assesses five dimensions: previous falls, medication, sensory deficits, mental state, and gait [27]. The J.H. Downton scale has a sensitivity of 0.58 and specificity of 0.63. Scores were interpreted as follows: 0 points = no risk, 1–2 points = low/moderate risk, and ≥3 points = high risk [28]. The J.H. Downton falls risk scale was selected as a tool for the detection of the risk of falls by the Regional Health Management of Castile & León in consensus with the 14 hospitals of the region.

2.2.2. Frailty Identification

Patients classified as frail were identified using Fried’s five criteria [9]:
1.
Unintentional weight loss >4.5 kg or >5.0% (in the past year).
2.
Generalised exhaustion (low energy and endurance measured by the CES-D depression scale [29]).
3.
Weakness (handgrip strength adjusted for sex and body mass index using a hand dynamometer, the JAMAR® Plus (Performance Health Supply, Inc., Cedarburg, WI, USA) digital hand-held dynamometer with LCD display (0–90 kg)).
4.
Walking speed (time to cover 4.57 m adjusted for sex and height).
5.
Weekly physical activity (Minnesota Leisure Time Activity Questionnaire [MLTAQ] stratified by sex; men: 383 kcal/week, women: 270 kcal/week [30]).
Patients were classed based on the number of criteria they met:
  • Frail: three or more criteria.
  • Pre-frail: one or two criteria.
  • Non-frail: no criteria.

2.2.3. Functional Dependency

Functional dependency was assessed using the Barthel index, which has a Cronbach’s alpha of 0.70 [31]. Scores were categorised in the following manner:
  • 0–20: total dependence;
  • 21–60: severe dependence;
  • 61–90: moderate dependence;
  • 91–99: minimal dependence;
  • 100: independence.

2.3. Description of Variables

The following variables were considered:
  • Sociodemographic variables: sex (biological attribute); age.
  • Dependent variable: fall risk (yes/no); score on the J.H. Downton scale.
  • Independent variables; the following independent variables were considered:
1.
Frailty status.
2.
Clinical variables: main diagnosis (coronary heart disease; infectious endocarditis; heart failure; arrhythmias; heart transplant; and valvular diseases); diabetes mellitus (yes/no); readmission to the cardiology unit (yes/no); presence of dyspnoea at admission (yes/no); presence of chest pain at admission (yes/no); systolic blood pressure (SBP; mmHg); diastolic blood pressure (DBP; mmHg); heart rate (HR; beats per minute); oxygen saturation (SpO2; %); and blood glucose (mg/dL).
3.
Anthropometric variables: height (cm); weight (kg); waist circumference (cm); body mass index (BMI; kg/m2: overweight (≥25 kg/m2), obesity (≥30 kg/m2)).
4.
Length of stay: number of hospitalisation days.

2.4. Procedure

A maximum of three days from the day of admission was established for data collection. Patients meeting the inclusion criteria were informed about the study, and after obtaining their informed consent, the following data were extracted from their electronic health records: sex, age, primary diagnosis, diabetes mellitus status, readmission to the cardiology unit, presence of dyspnoea, SBP, DBP, HR, SpO2, and blood glucose levels. At admission, the degree of dependency was systematically assessed using the Barthel index, and fall risk was screened using the J.H. Downton scale, with scores of 1 or higher considered positive.
Anthropometric measures such as height, weight, and BMI were recorded, and Fried’s scale was applied to identify frail patients. The length of stay in days was documented for all participants upon hospital discharge.

2.5. Ethical Considerations

The anonymity and confidentiality of participant data were safeguarded using Research Electronic Data Capture (REDCap) software (https://project-redcap.org/), in compliance with the European Regulation 2016/679 of the European Parliament and of the Council of 27 April 2016 and Spanish Organic Law 3/2018, of 5 December, on the Protection of Personal Data and the Guarantee of Digital Rights. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the relevant Valladolid Ethics Committee for Research with medicinal products (ECRmp) involving humans under the reference code PI-20-1612 on 23 January 2020.

2.6. Statistical Analysis

Data normality was assessed using the Kolmogorov–Smirnov test, kurtosis, and skewness. Quantitative variables were presented as means and standard deviations (SDs), while categorical variables were expressed as frequency distributions. Quantitative variables were compared using Student’s t-test, categorical variables with Pearson’s chi-squared test, and comparisons among three groups using the Kruskal–Wallis test. Homogeneity of variance was evaluated using Levene’s test.
Univariate binary logistic regression was employed to identify factors associated with frailty and fall risk, with adjusted odds ratios (ORs) calculated for the included variables. A confidence interval of 95% and a statistical significance level of p < 0.05 were applied.
Statistical analyses were performed using IBM® SPSS® Statistics v.26 software (SPSS, Inc., Chicago, IL, USA).

3. Results

3.1. Descriptive Analysis

During the study period, 148 patients were recruited, of which 4 patients were excluded from the study as the necessary data collection could not be completed (33.30% women, n = 48; 66.70% men, n = 96), with a mean age of 73.08 years (SD = 7.95). The most prevalent diagnosis was coronary heart disease (61.11%). Diabetes mellitus was present in 36.11% of patients, while 35.42% reported chest pain at admission, and 30.56% presented with dyspnoea.
Regarding frailty, 33.30% of patients were classed as frail. Fall risk was identified in 97.22% of participants, with 36.81% of the total sample considered at high or very high risk (Table 1).
The mean Downton score indicated a low/moderate fall risk (2.24 points; SD = 1.25). The Barthel index showed a mean score of 95.76 points (SD = 9.28), reflecting a minimal level of dependency in most patients. The mean BMI fell within the overweight category ( X ¯ = 27.69 kg/m2; SD = 4.35), and the mean waist circumference exceeded 100 cm. The mean overall hospital stay was 8.66 days (SD = 5.56), while patients at high fall risk experienced a longer mean stay of 9.71 days (SD = 7.39) (Table 2).
After analysing the data by sex, the mean age was similar between men and women, as was the Downton score. Women were proportionally frailer and had a lower mean score on the Barthel index (93.54 points; SD = 12.80). There were no differences in mean BMI (men: X ¯ = 27.71 kg/m2; SD = 4.09; women: X ¯ = 27.67 kg/m2; SD = 4.89). However, the mean waist circumference was larger in men than in women. The mean length of the hospital stay was longer among men ( X ¯ = 9.40 days; SD = 6.13) compared to women ( X ¯ = 7.11 days; SD = 3.78). The mean hospital stay duration in those patients with frailty was higher, both in the overall sample ( X ¯ = 10.65; SD = 6.98) and in the sex analysis (men: X ¯ = 12.35; SD = 8.24 vs. women: X ¯ = 7.86; SD = 2.86) (Table 2).
The most prevalent diagnosis was coronary heart disease. The proportion of patients with diabetes was higher among men (39.58%). Fall risk was greater among frail and pre-frail women compared to other groups (37.50% and 43.80%, respectively) (Table 3).
When analysing the frailty distribution within the high/very high fall risk group, 45.30% of the patients were classified as frail. Women in this group exhibited a higher percentage of pre-frailty compared to men (42.10% vs. 17.60%). This group of patients had a mean hospital stay of 12.06 days (SD = 9.05).
According to the J.H. Downton scale, the most frequently used category of medications among patients was other medications (27.10%), followed by non-diuretic antihypertensives taken in combination with other drugs (16.00%). Notably, 99.30% of the patients were taking at least one medication during the assessment (Table 4).

3.2. Comparison Between Frailty Status and Demographic and Clinical Variables

A comparative analysis between categorical variables and frailty status revealed statistically significant differences in gait (assessed within the Downton scale) (χ2 = 25.14; df = 10; p < 0.00); social risk (χ2 = 8.88; df = 2; p < 0.01); and gender (χ2 = 5.99; df = 2; p < 0.05). However, no significant differences were found with risk of falls (χ2 = 0.62; df = 2; p = 0.73).
Regarding quantitative variables, significant differences were observed between non-frail and frail patients in diastolic blood pressure (t = 2.19; df = 92; p = 0.03); waist circumference (t = −2.22; df = 91; p = 0.02); length of hospital stay (t = −2.74; df = 92; p = 0.00); and height (t = 2.96; df = 92; p < 0.00).
Among women, a significant association was observed between frailty status (frail and non-frail) and diastolic blood pressure (t = −2.06; df = 25; p = 0.05). In men, waist circumference was significantly associated with frailty status (frail vs. non-frail) (t = −2.61; df = 65; p = 0.01).
In the analysis of the three frailty groups (frail, pre-frail, and non-frail), statistically significant differences were found in the following variables: Downton score (H = 7.73; df = 2; p = 0.02); Barthel index (H = 25.68; df = 2; p = 0.00); length of hospital stay (H = 6.97; df = 2; p = 0.03); waist circumference (H = 6.78; df = 2; p = 0.03); age (H = 19.75; df = 2; p = 0.00); and height (H = 6.75; df = 2; p = 0.03) (Table 5).
Among women, a significant association was observed between frailty status and the Barthel index in the Pre-frail–Frail group (H = 7.71; p = 0.04). For men, a significant association was found in the Frail–Non-frail group (H = 14.00; p < 0.00).

3.3. Logistic Regression Analysis

No significant association was found between risk of falls and frailty status (OR: 0.959; 95% CI: 0.058–15.752; p = 0.977). However, waist circumference was significantly associated with risk of falls (OR: 1.063; 95% CI: 1.003–1.125; p = 0.038).
With respect to age, for every year, older patients are 1.114 times more likely to be frail.
Frailty status was directly related to Downton scores, age, Barthel index, oxygen saturation (SpO2), diastolic blood pressure, and waist circumference. No statistically significant relationship was observed with sex (Table 6).
When examining the relationship between frailty and specific items from the Downton scale, the use of diuretics, sensory deficits in the extremities, and gait were significantly associated with frailty (Table 7).
A statistically significant relationship was observed between coronary heart disease and frailty status. Coronary artery disease was the only clinical diagnosis at admission that was inversely related to frailty status in a statistically significant manner. Patients admitted with coronary artery disease were 5.64 times less likely to be frail (Table 8).

4. Discussion

Scientific cardiology societies should prioritise including frail patients with cardiovascular disease (CVD) in their research projects in order to optimise their clinical management, particularly considering the existing link between frailty and risk of falls [32,33].
Our study identified a relationship between frailty status and scores on the J.H. Downton scale, with frail hospitalised cardiac patients scoring higher and, thus, facing a greater risk of falls. However, no significant association was found between frailty status and binary fall risk (Yes/No), as determined by the same scale. This finding aligns with a study conducted on a rural Ecuadorian population aged ≥60 years (OR: 0.63; 95% CI: 0.29–1.36; p = 0.237), but contrasts with Yang et al.’s meta-analysis (RR: 1.48; 95% CI: 1.27–1.73; p < 0.05) [14,34]. These differences could be attributed to the use of varied tools for assessing both frailty and fall risk.
The limited predictive value of the J.H. Downton scale has been noted by other researchers, who have emphasised the critical role of nurses’ clinical judgement. In hospital settings, the Downton scale may overidentify fall risk, as the threshold begins at just 1 point. Despite its widespread use, pairing it with another tool that captures the multifactorial nature of fall risk is recommended [28,35,36].
Although no statistically significant relationship was found between frailty and fall risk by sex, differences were observed in related factors such as blood pressure and waist circumference. Previous studies have linked frailty in women to higher mortality (hazard ratio [HR]: 0.65; 95% CI: 0.58–0.74; p < 0.001) [37].
Larger waist circumference in this study was associated with increased fall risk, consistent with Bu et al.’s findings (OR: 0.98; 95% CI: 0.96–1.00; p = 0.017) [38]. Polypharmacy is also a well-documented fall risk factor in CVD patients. In this study, frail patients were more likely to use diuretics than their non-frail counterparts. Diuretics are among the drugs most commonly linked to fall risk in this population, as highlighted by the American Heart Association [32].
The prevalence of frailty in our study was lower than reported in other non-community settings but higher than in community settings [1,39]. Differences in frailty assessment tools, population groups, and identification criteria continue to hinder the development of standardised protocols [40].
In one out of three patients with diabetes, frailty status could be identified, although no relationship between these two conditions could be established, as in the study by Xu et al. [12]. However, other authors have identified diabetes as a factor associated with frailty that may increase the risk of developing it (RR: 1.10, 95% CI: 1.01–1.20, p = 0.04). Among the CVD diagnoses included in the study, frailty was only significantly associated with coronary heart disease. This contrasts with findings from Wang, Hu, and Wu, who found no overall relationship between frailty and CVD (RR: 1.00; 95% CI: 0.92–1.09; p = 0.95) [18]. Liperoti et al. estimated that nearly one-fifth of patients with ischaemic heart disease were frail but did not establish a clear link [41]. While frailty is often associated with heart failure [42], this was not statistically significant in our study. Diastolic blood pressure was inversely related to frailty, suggesting that frail patients tended to have lower diastolic pressures. This finding aligns with previous studies [43], although Vetrano et al. reported a relationship between frailty and hypertension (pooled OR: 1.33; 95% CI: 0.94–1.89; I2 = 79.2%) [44]. Age also emerged as a significant factor, with increasing age linked to higher frailty risk, consistent with prior studies ([OR: 1.15; 95% CI: 1.09–1.21; p < 0.001]; [OR: 3.910; 95% CI: 2.021–5.402; p < 0.05]) [34,45].
Frail patients also experienced longer hospital stays, with men staying the longest. When combined with fall risk, hospital stays extended to a mean of 12.06 days, likely increasing institutional costs [10].
Through the BPSO programme of the RNAO, the J.H. Downton scale has been implemented since 2019 in the 14 hospitals of the Castile & León region to assess the risk of falls in hospitalised patients. It is considered that patients with a score of 1 are already at risk, and it would be desirable to modify the criteria for risk designation or opt for another scale that fits the hospital setting. This will contribute to the design of new care management strategies in terms of fall risk detection and the identification of frailty in the hospital setting, increasing patient safety and deepening this line of research for the development of specific care plans to facilitate a more sustainable health system.

4.1. Limitations

The main limitation of this study was the sample size; the participants were selected through convenience sampling. A larger sample would have allowed for greater generalisability of results. However, the study objectives were successfully addressed. Future studies should examine factors influencing the relationship between frailty and fall risk for each clinical diagnosis and include a wider range of hospital settings.

Future Lines of Research

Larger, more diverse samples are essential to generalise findings and uncover the complex relationship between frailty, risk of falls, and cardiovascular conditions. Developing multifactorial models that combine clinical and demographic variables could transform personalised care for these patients.

5. Conclusions

Older frail adults hospitalised with cardiac disease have longer average hospital stays. Frailty was directly associated with Downton scores in hospitalised older adult patients with cardiac conditions. In this study, 33.30% of patients were classed as frail, and 97.22% were at risk of falls. Women at high fall risk were proportionally frailer than men in the same situation. Frail patients also had longer hospital stays than their non-frail counterparts.
As the older population grows worldwide, the number of individuals with CVD who are frail and at risk of falls is expected to increase. Identifying shared characteristics within this population can help standardise assessment tools and improve clinical management, leading to better outcomes for patients and institutions alike. Combining frailty and fall risk scales in hospitalised older adults with cardiac conditions can refine prognostic accuracy, address comorbidities, and reduce hospital stays. Tailoring interventions to the differences between men and women is equally important for effective management.

Author Contributions

N.R.-G. conducted the literature review. N.R.-G., M.L. and M.J.C. designed the study. N.R.-G., M.F.-C. and B.M.-G. analysed the findings. N.R.-G., M.L., M.J.C. and J.A.S.R. drafted the final version of the manuscript. N.R.-G., M.F.-C. and B.M.-G. adapted the manuscript to the journal’s style requirements. All authors have read and agreed to the published version of the manuscript.

Funding

The study was funded by a grant awarded by the Castile & León Regional Health Management Board under reference code GRS 2706/A/23. The financial sponsors had no involvement in the design, conduct, analysis, or interpretation of the data, nor in the preparation or writing of the manuscript.

Institutional Review Board Statement

The study was conducted in accordance with the principles set out in the Declaration of Helsinki and approved by the Valladolid Ethics Committee for Research with medicinal products (ECRmp) involving humans under the reference code PI-20-1612 on 23 January 2020.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Public Involvement Statement

No public involvement in any aspect of this research.

Guidelines and Standards Statement

This manuscript was drafted in alignment with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for observational research [43].

Use of Artificial Intelligence

AI or AI-assisted tools were not used in drafting any aspect of this manuscript.

Acknowledgments

The authors would like to thank the cardiology department nurses at the Valladolid University Clinical Hospital for their invaluable collaboration.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
CVDsCardiovascular diseases
BPSO®Best Practice Spotlight Organisations
RRRelative risk
SBPSystolic blood pressure
DBPDiastolic blood pressure
HRHeart rate
SpO2Oxygen saturation
BMIBody mass index
RedCAPResearch Electronic Data Capture
ECRmpEthics Committee for Research with medicinal products
SDStandard deviation
OROdds ratio
CIConfidence interval
HRHazard ratio

References

  1. Doody, P.; Lord, J.M.; Greig, C.A.; Whittaker, A.C. Frailty: Pathophysiology, Theoretical and Operational Definition(s), Impact, Prevalence, Management and Prevention, in an Increasingly Economically Developed and Ageing World. Gerontology 2023, 69, 927–945. [Google Scholar] [CrossRef] [PubMed]
  2. Kane, A.E.; Howlett, S.E. Sex differences in frailty: Comparisons Between Humans and Preclinical Models. Mech. Ageing Dev. 2021, 198, 111546. [Google Scholar] [CrossRef] [PubMed]
  3. Regitz-Zagrosek, V.; Gebhard, C. Gender medicine: Effects of sex and gender on cardiovascular disease manifestation and outcomes. Nat. Rev. Cardiol. 2023, 20, 236–247. [Google Scholar] [CrossRef] [PubMed]
  4. Jylhävä, J.; Pedersen, N.L.; Hägg, S. Biological Age Predictors. EBioMedicine 2017, 21, 29–36. [Google Scholar] [CrossRef]
  5. World Health Organization. Envejecimiento y Salud. 2022. Available online: https://www.who.int/es/news-room/fact-sheets/detail/ageing-and-health (accessed on 22 October 2024).
  6. Lindstrom, M.; Decleene, N.; Dorsey, H.; Fuster, V.; Johnson, C.O.; Legrand, K.E.; Mensah, G.A.; Razo, C.; Stark, B.; Turco, J.V.; et al. Summary of Global Burden of Disease Study Methods. J. Am. Coll. Cardiol. 2022, 80, 2372–2425. [Google Scholar] [CrossRef]
  7. Maas, A.H.E.M.; Rosano, G.; Cifkova, R.; Chieffo, A.; Van Dijken, D.; Hamoda, H.; Kunadian, V.; Laan, E.; Lambrinoudaki, I.; Maclaran, K.; et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: A consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur. Heart J. 2021, 42, 967–984. [Google Scholar] [CrossRef]
  8. Hart, E.C.J.; Charkoudian, N. Sympathetic neural regulation of blood pressure: Influences of sex and aging. Physiology 2014, 29, 8–15. [Google Scholar] [CrossRef]
  9. Fried, L.P.; Tangen, C.M.; Walston, J.; Newman, A.B.; Hirsch, C.; Gottdiener, J.; Seeman, T.; Tracy, R.; Kop, W.J.; Burke, G.; et al. Frailty in older adults: Evidence for a phenotype. J. Gerontol.-Ser. A Biol. Sci. Med. Sci. 2001, 56, 146–157. [Google Scholar] [CrossRef]
  10. Hoogendijk, E.O.; Afilalo, J.; Ensrud, K.E.; Kowal, P.; Onder, G.; Fried, L.P. Frailty: Implications for clinical practice and public health. Lancet 2019, 394, 1365–1375. [Google Scholar] [CrossRef]
  11. Collard, R.M.; Boter, H.; Schoevers, R.A.; Oude Voshaar, R. Prevalence of frailty in community-dwelling older persons: A systematic review. J. Am. Geriatr. Soc. 2012, 60, 1487–1492. [Google Scholar] [CrossRef]
  12. Xu, Q.; Ou, X.; Li, J. The risk of falls among the aging population: A systematic review and meta-analysis. Front. Public Health 2022, 10, 902599. [Google Scholar] [CrossRef] [PubMed]
  13. Chen, L.; Li, X.; Lv, Y.; Tan, X.; Zhong, V.W.; Rong, S.; Liu, G.; Liu, L. Physical frailty, adherence to ideal cardiovascular health and risk of cardiovascular disease: A prospective cohort study. Age Ageing 2023, 52, 1–9. [Google Scholar] [CrossRef] [PubMed]
  14. Magnussen, C.; Niiranen, T.J.; Ojeda, F.M.; Gianfagna, F.; Blankenberg, S.; Njølstad, I. Sex Dif-ferences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors and Mortality in Community Cohorts: Results from the BiomarCaRE Consortium. Circulation 2018, 136, 1588–1597. [Google Scholar] [CrossRef] [PubMed]
  15. Wilkinson, C.; Todd, O.; Clegg, A.; Gale, C.P.; Hall, M. Management of atrial fibrillation for older people with frailty: A systematic review and meta-analysis. Age Ageing 2019, 48, 196–204. [Google Scholar] [CrossRef]
  16. Yang, Z.C.; Lin, H.; Jiang, G.H.; Chu, Y.H.; Gao, J.H.; Tong, Z.J.; Wang, Z. Frailty Is a Risk Factor for Falls in the Older Adults: A Systematic Review and Meta-Analysis. J. Nutr. Health Aging 2023, 27, 487–495. [Google Scholar] [CrossRef]
  17. O’Halloran, A.M.; Cremers, J.; Vrangbæk, K.; Roe, L.; Bourke, R.; Mortensen, L.H.; Westendorp, R.G.J.; Kenny, R.A. Cardiovascular disease and the risk of incident falls and mortality among adults aged ≥65 years presenting to the emergency department: A cohort study from national registry data in Denmark. BMC Geriatr. 2024, 24, 93. [Google Scholar] [CrossRef]
  18. Wang, X.; Hu, J.; Wu, D. Risk factors for frailty in older adults. Medicine 2022, 101, E30169. [Google Scholar] [CrossRef]
  19. World Health Organization. WHO Global Report on Falls Prevention in Older Age; WHO: Geneva, Switzerland, 2007; pp. 1–47. [Google Scholar]
  20. Stevens, J.; Ryan, G.; Kresnow, M. Fatalities and injuries from falls among older adults United States, 1993–2003 and 2001–2005. JAMA Intern. Med. 2007, 297, 32–33. [Google Scholar]
  21. Currie, L. Chapter 10. Fall and Injury Prevention. In Patient Safety and Quality: An Evidence-Based Handbook for Nurses; U.S. Department of Health and Human Services: Rockville, MD, USA, 2008; pp. 1–56. [Google Scholar]
  22. LeLaurin, J.H.; Shorr, R.I. Preventing Falls in Hospitalized Patients: State of the Science. Clin. Geriatr. Med. 2019, 35, 273–283. [Google Scholar] [CrossRef]
  23. González-María, E.; Moreno-Casbas, M.T.; Albornos-Muñoz, L.; Grinspun, D.; Grupo de Trabajo del Programa de Implantación de Buenas Prácticas en Centros Comprometidos con la Excelencia en Cuidado. The implementation of Best practice guidelines in Spain through the Programme of the Best Practice Spotlight Organizations®. Enferm. Clin. 2020, 30, 136–144. [Google Scholar] [CrossRef]
  24. Barker, A.L.; Morello, R.T.; Wolfe, R.; Brand, C.A.; Haines, T.P.; Hill, K.D.; Brauer, S.G.; Botti, M.; Cumming, R.G.; Livingston, P.M.; et al. 6-PACK programme to decrease fall injuries in acute hospitals: Cluster randomised controlled trial. BMJ 2016, 352, h6781. [Google Scholar] [CrossRef] [PubMed]
  25. Morello, R.T.; Barker, A.L.; Ayton, D.R.; Landgren, F.; Kamar, J.; Hill, K.D.; Brand, C.A.; Sherrington, C.; Wolfe, R.; Rifat, S.; et al. Implementation fidelity of a nurse-led falls prevention program in acute hospitals during the 6-PACK trial. BMC Health Serv. Res. 2017, 17, 1–10. [Google Scholar] [CrossRef] [PubMed]
  26. RNAO. RNA of O. Prevención de Caídas y Disminución de Lesiones Derivadas de las Caídas. Bpso. 2017, pp. 103–112. Available online: https://www.bpso.es/wp-content/uploads/2020/01/D0021_Prevencion_Caidas_2017.pdf (accessed on 8 October 2024).
  27. Downton, J. Falls in the Elderly; Edward Arnold: London, UK, 1993. [Google Scholar]
  28. Bueno-García, M.J.; Roldán-Chicano, M.T.; Rodríguez-Tello, J.; Meroño-Rivera, M.D.; Dávila-Martínez, R.; Berenguer-García, N. Características de la escala Downton en la valoración del riesgo de caídas en pacientes hospitalizados. Enferm. Clin. 2017, 27, 227–234. [Google Scholar] [CrossRef] [PubMed]
  29. Radloff, L.S. TheCES-DScale:ASelf-ReportDepressionScaleforResearchintheGeneralPopulation. Appl. Psychol. Meas. 1977, 1, 385–401. [Google Scholar] [CrossRef]
  30. Ruiz Comellas, A.; Pera, G.; Baena Díez, J.M.; Mundet Tudurí, X.; Alzamora Sas, T.; Elosua, R.; Torán Monserrat, P.; Heras, A.; Forés Raurell, R.; Fusté Gamisans, M.; et al. Validation of a Spanish Short Version of the Minnesota Leisure Time Physical Activity Questionnaire (VREM). Rev. Esp. Salud. Publica 2012, 86, 495–508. [Google Scholar]
  31. Mahoney, F.I.; Barthel, D.W. Functional Evaluation: The Barthel Index. Md. State Med. J. 1965, 14, 61–65. [Google Scholar]
  32. Denfeld, Q.E.; Turrise, S.; MacLaughlin, E.J.; Chang, P.S.; Clair, W.K.; Lewis, E.F.; Forman, D.E.; Goodlin, S.J. Preventing and Managing Falls in Adults With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circ. Cardiovasc. Qual. Outcomes 2022, 15, E000108. [Google Scholar] [CrossRef]
  33. Richter, D.; Guasti, L.; Walker, D.; Lambrinou, E.; Lionis, C.; Abreu, A.; Savelieva, I.; Fumagalli, S.; Bo, M.; Rocca, B.; et al. Frailty in cardiology: Definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS). Eur. J. Prev. Cardiol. 2022, 29, 216–227. [Google Scholar]
  34. Del Brutto, O.H.; Mera, R.M.; Peinado, C.D.; Zambrano, M.; Sedler, M.J. Frailty and Risk of Falls in Community-Dwelling Older Adults Living in a Rural Setting. The Atahualpa Project. J. Frailty Aging 2020, 9, 150–154. [Google Scholar] [CrossRef]
  35. Meyer, G.; Köper, S.; Haastert, B.; Mühlauser, I. Comparison of a fall risk assessment tool with nurses’ judgement alone: A cluster-randomised controlled trial. Age Ageing 2009, 38, 417–423. [Google Scholar] [CrossRef]
  36. Park, S.H. Tools for assessing fall risk in the elderly: A systematic review and meta-analysis. Aging Clin. Exp. Res. 2018, 30, 1–16. [Google Scholar] [CrossRef] [PubMed]
  37. Jayanama, K.; Theou, O.; Godin, J.; Cahill, L.; Shivappa, N.; Hébert, J.R.; Wirth, M.D.; Park, Y.M.; Fung, T.T.; Rockwood, K. Relationship between diet quality scores and the risk of frailty and mortality in adults across a wide age spectrum. BMC Med. 2021, 19, 64. [Google Scholar] [CrossRef] [PubMed]
  38. Bu, F.; Deng, X.H.; Zhan, N.N.; Cheng, H.; Wang, Z.L.; Tang, L.; Zhao, Y.; Lyu, Q. Development and validation of a risk prediction model for frailty in patients with diabetes. BMC Geriatr. 2023, 23, 172. [Google Scholar] [CrossRef]
  39. O’Caoimh, R.; Galluzzo, L.; Rodríguez-Laso, Á.; Van der Heyden, J.; Ranhoff, A.H.; Lamprini-Koula, M.; Ciutan, M.; Samaniego, L.L.; Carcaillon-Bentata, L.; Kennelly, S.; et al. Prevalence of frailty at population level in European ADVANTAGE Joint Action Member States: A systematic review and meta-analysis. Ann. dell’Ist. Super. Sanità 2018, 54, 226–238. [Google Scholar]
  40. Galluzzo, L.; O’Caoimh, R.; Rodríguez-Laso, Á.; Beltzer, N.; Ranhoff, A.H.; Van der Heyden, J.; Lamprini-Koula, M.; Ciutan, M.; López-Samaniego, L.; Liew, A. Incidence of frailty: A systematic review of scientific literature from a public health perspective. Ann. dell’Ist. Super. Sanita 2018, 54, 239–245. [Google Scholar]
  41. Liperoti, R.; Vetrano, D.L.; Palmer, K.; Targowski, T.; Cipriani, M.C.; Lo Monaco, M.R.; Giovannini, S.; Acampora, N.; Villani, E.R.; Bernabei, R.; et al. Association between frailty and ischemic heart disease: A systematic review and meta-analysis. BMC Geriatr. 2021, 21, 357. [Google Scholar] [CrossRef]
  42. Denfeld, Q.E.; Winters-Stone, K.; Mudd, J.O.; Gelow, J.M.; Kurdi, S.; Lee, C.S. The prevalence of frailty in heart failure: A systematic review and meta-analysis. Int. J. Cardiol. 2017, 236, 283–289. [Google Scholar] [CrossRef]
  43. Gu, Y.; Wan, Y.; Ren, J.H.; Zhao, Y.; Wang, Y.; Shen, J.H. Analysis of systolic and diastolic blood pressure variability in frail, pre-frail, and non-frail elderly patients: The relationship between frailty syndrome and blood pressure variability in the elderly. Medecine 2023, 102, e32874. [Google Scholar] [CrossRef]
  44. Vetrano, D.L.; Palmer, K.M.; Galluzzo, L.; Giampaoli, S.; Marengoni, A.; Bernabei, R.; Onder, G. Hypertension and frailty: A systematic review and meta-analysis. BMJ Open 2018, 8, 1–8. [Google Scholar] [CrossRef]
  45. Von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gotzsche, P.C.; Vandenbroucke, J.P.; STROBE Initiative. The Strengthening the Reporting of Observational studies in Epidemiology-STROBE-statement: Guidelines for reporting observational studies. Lancet 2007, 370, 1453–1457. [Google Scholar] [CrossRef]
Table 1. Sample description.
Table 1. Sample description.
n = 144Men
n = 96
Women
n = 48
Frail n = 48Non-Frail n = 46Pre-Frail
n = 50
nnnTotal% Total
DiagnosisArrhythmiasSexMale33174.86%
Female21585.56%
Total5461510.42%
Infectious endocarditisSexMale10121.39%
Female00000.00%
Total10121.39%
Heart failureSexMale7862114.58%
Female51285.56%
Total12982920.14%
Coronary heart diseaseSexMale1526206142.36%
Female87122718.75%
Total2333328861.11%
Heart transplantSexMale10010.69%
Female00000.00%
Total10010.69%
Valvular diseaseSexMale30142.78%
Female30253.47%
Total60396.25%
ReadmissionNOSexMale2334268357.64%
Female158194229.17%
Total38424512586.81%
YESSexMale733139.03%
Female31264.17%
Total10451913.19%
Diabetes mellitusNOSexMale1627155840.28%
Female127153423.61%
Total2834309263.89%
YESSexMale1410143826.39%
Female626149.72%
Total2012205236.11%
Chest painNOSexMale1923226444.44%
Female125122920.14%
Total3128349364.58%
YESSexMale111473222.22%
Female6491913.19%
Total1718165135.42%
DyspnoeaNOSexMale1828216746.53%
Female127143322.92%
Total30353510069.44%
YESSexMale12982920.14%
Female6271510.42%
Total1811154430.56%
Risk of falls (Downton)NOSexMale02132.08%
Female10010.69%
Total12142.78%
YESSexMale3035289364.58%
Female179214732.64%
Total47444914097.22%
High/very high risk of falls (Downton > 3)YESSexMale161263435.42%
Female8382139.58%
Total2415145336.81%
Low/moderate risk of falls
(Downton 1–2)
YESSexMale1423225961.46%
Female96131633.33%
Total2329358760.42%
Table 2. Descriptive statistics of quantitative variables in the total sample, by frailty status, according to Fried’s criteria and sex.
Table 2. Descriptive statistics of quantitative variables in the total sample, by frailty status, according to Fried’s criteria and sex.
n = 144Frail
n = 48
Non-Frail
n = 46
Pre-Frail
n = 50
Sex
Male(M) = 96
Female
(F) = 48
Frail
M(31.30%)
F(37.50%)
Non-Frail
M(38.50%)
F(18.80%)
Pre-Frail
M(30.20%)
F(43.80%)
Mean ( X ¯ )
Standard deviation (SD)
Age (years)73.08
7.95
77.08
8.09
72.35
6.52
69.92
7.50
M73.14
7.94
76.63
8.24
73.65
6.49
68.86
7.54
F72.98
8.06
77.83
8.01
67
3.04
71.38
7.38
Downton (points)2.24
1.25
2.69
1.49
1.98
1.16
2.04
0.95
M2.25
1.26
2.93
1.55
1.92
1.04
1.97
0.91
F2.21
1.24
2.28
1.32
2.22
1.64
2.14
1.01
Barthel index (points)95.76
9.28
90.83
12.17
98.91
4.20
97.60
7.51
M96.88
6.70
92.83
9.35
98.65
4.66
98.79
2.88
F93.54
12.80
87.5
15.55
100
0
95.95
11.02
Oxygen saturation (%)94.99
2.58
94.38
2.92
95.52
1.75
95.10
2.80
M94.85
2.83
94.1
3.5
95.41
1.80
94.93
3.05
F95.27
2.01
94.83
1.54
96
1.50
95.33
2.48
Heart rate (bpm)73.47
16.34
73.56
15.48
75.17
18.36
71.80
15.29
M71.97
16.31
73.1
17
72.19
16.79
70.52
15.39
F76.46
16.14
74.33
12.98
87.44
20.40
73.57
15.35
Systolic blood pressure (mmHg)124.17
19.59
125.60
21.08
123.20
19.82
123.70
18.18
M125.84
18.34
126.7
17.65
126.81
19.67
123.72
17.73
F120.83
21.71
123.78
26.29
108.33
12.61
123.67
19.23
Diastolic blood pressure (mmHg)70.84
10.21
68.33
11.21
72.65
7.42
71.58
11.10
M71.92
9.96
69.87
11.24
72.73
7.36
73
11.37
F68.69
10.48
65.78
11.01
72.33
8.12
69.62
10.68
Blood glucose (mg/dl)134.62
52.78
137.08
61.79
135.46
54.86
131.48
41.07
M134.91
49.35
134.87
54.96
134.46
50.57
135.52
42.95
F134.04
59.61
140.78
73.35
139.56
73.47
125.9
38.64
Waist circumference (cm)102.96
12.83
106.23
12.14
101.25
9.25
101.45
15.65
M104.83
10.82
108
11.32
101.58
8.78
105.71
11.82
F99.13
15.62
103.12
13.24
99.89
11.46
95.57
18.48
Length of stay (days)8.66
5.56
10.65
6.98
7.03
4.00
8.30
4.79
M9.40
6.13
12.35
8.24
7.33
4.29
9.14
5.64
F7.11
3.78
7.86
2.53
5.71
2.13
7.42
4.47
Height (cm)164.44
7.87
162.43
7.81
166.71
6.02
164.28
8.94
M168.15
5.81
166.48
5.58
168.34
4.93
169.62
6.76
F157.02
5.99
155.67
6.17
160
5.66
156.9
5.79
Weight (kg)74.99
13.56
74.91
12.96
75.25
10.32
74.82
16.67
M78.36
12.76
78.7
11.81
76.28
9.76
80.66
16.57
F68.25
12.68
68.6
12.62
70.98
12.01
66.77
13.39
BMI (kg/m2)27.69
4.35
28.46
4.82
27.09
3.54
27.51
4.54
M27.71
4.09
28.51
4.62
26.94
3.37
68.86
7.54
F27.67
4.89
28.38
5.27
27.72
4.34
71.38
7.38
Table 3. Distribution of total categorical variables by sex and frailty status.
Table 3. Distribution of total categorical variables by sex and frailty status.
Categorical Variables % n = 144Sex
(Men: n = 96; Women: n = 48)
%
Within Sex
FrailNon-FrailPre-Frail
DiagnosisArrythmias10.42%Male7.29%3.13%3.13%1.04%
Female16.67%4.17%2.08%10.42%
Total 7.29%5.21%11.46%
Infectious endocarditis1.39%Male2.08%1.04%0.00%1.04%
Female0.00%0.00%0.00%0.00%
Total 1.04%0.00%1.04%
Heart failure20.14%Male21.88%7.29%8.33%6.25%
Female16.67%10.42%2.08%4.17%
Total 17.71%10.42%10.42%
Coronary heart disease61.11%Male63.54%15.63%27.08%20.83%
Female56.25%16.67%14.58%25.00%
Total 32.29%41.67%45.83%
Heart transplant0.69%Male1.04%1.04%0.00%0.00%
Female0.00%0.00%0.00%0.00%
Total 1.04%0.00%0.00%
Valvular disease6.25%Male4.17%3.13%0.00%1.04%
Female10.42%6.25%0.00%4.17%
Total 9.38%0.00%5.21%
ReadmissionNO86.81%Male89.58%23.96%35.42%27.08%
Female87.50%31.25%16.67%39.58%
Total 55.21%52.08%66.67%
YES13.19%Male13.54%7.29%3.13%3.13%
Female12.50%6.25%2.08%4.17%
Total 13.54%5.21%7.29%
Diabetes mellitusNO63.89%Male60.42%16.67%28.13%15.63%
Female70.83%25.00%14.58%31.25%
Total 41.67%42.71%46.88%
YES36.11%Male39.58%14.58%10.42%14.58%
Female29.17%12.50%4.17%12.50%
Total 27.08%14.58%27.08%
Chest painNO64.58%Male66.67%19.79%23.96%22.92%
Female60.42%25.00%10.42%25.00%
Total 44.79%34.38%47.92%
YES35.42%Male33.33%11.46%14.58%7.29%
Female39.58%12.50%8.33%18.75%
Total 23.96%22.92%26.04%
DyspnoeaNO69.44%Male69.79%18.75%29.17%21.88%
Female68.75%25.00%14.58%29.17%
Total 43.75%43.75%51.04%
YES30.56%Male30.21%12.50%9.38%8.33%
Female31.25%12.50%4.17%14.58%
Total 25.00%13.54%22.92%
Risk of falls (Downton)NO2.78%Male3.13%0.00%2.08%1.04%
Female2.08%2.08%0.00%0.00%
Total 2.08%2.08%1.04%
YES97.22%Male96.98%31.25%36.46%29.17%
Female97.92%35.42%18.75%43.75%
Total 66.67%55.21%72.92%
Table 4. Distribution of the most common medications used by patients assessed with the J.H. Downton scale.
Table 4. Distribution of the most common medications used by patients assessed with the J.H. Downton scale.
Type of Medication% (n = 144)
Antihypertensives2.80
Non-diuretic antihypertensives14.60
Antidepressants0.70
Antiparkinsonians2.10
Diuretics3.50
Tranquillisers/sedatives6.30
Diuretics and antihypertensives3.50
Diuretics and non-diuretic antihypertensives3.50
Diuretics and antidepressants0.70
Diuretics and other medications2.80
Other medications and non-diuretic antihypertensives16.00
Tranquillisers/sedatives and non-diuretic antihypertensives1.40
Tranquillisers/sedatives and other medications1.40
Tranquillisers/sedatives, other medications, and non-diuretic antihypertensives2.10
Diuretics, other medications, and non-diuretic antihypertensives7.30
Tranquillisers/sedatives, antiparkinsonians, antidepressants, other medications, and non-diuretic antihypertensives0.70
Other medications27.10
None3.50
Table 5. Association between frailty groups and demographic and clinical variables.
Table 5. Association between frailty groups and demographic and clinical variables.
FriedVariableTest StatisticDev. ErrorDev. Test Statisticp-Value
Non-frail—Pre-frailDownton score−3.708.22−0.450.65
Non-frail—Frail21.458.302.580.01
Pre-frail—Frail17.748.132.180.03
Frail—Pre-frailBarthel index−24.586.64−3.690.00
Frail—Non-frail−32.926.78−4.850.00
Pre-frail—Non-frail8.346.721.240.21
Non-frail—Pre-frailLength of hospital stay−8.677.43−1.170.24
Non-frail—Frail19.587.432.640.00
Pre-frail—Frail10.907.431.470.14
Pre-frail—Non-frailWaist circumference1.008.460.120.91
Pre-frail—Frail19.658.412.340.02
Non-frail—Frail18.658.592.170.03
Pre-frail—Non-frailAge11.158.511.310.19
Pre-frail—Frail36.628.424.350.00
Non-frail—Frail25.478.602.960.00
Frail—Pre-frailHeight (cm2)−8.008.42−0.950.34
Frail—Non-frail−22.088.60−2.570.01
Pre-frail—Non-frail14.088.511.650.10
Table 6. Analysis of sociodemographic and clinical variables influencing frailty status in patients with cardiac conditions.
Table 6. Analysis of sociodemographic and clinical variables influencing frailty status in patients with cardiac conditions.
Clinical and Sociodemographic Variablesβ ErrorStandard ErrorWalddfpExp(β) (Odds Ratio)95% CI for Exp(β)
Lower limitUpper limit
Age0.1080.02616.73410.0001.1141.0581.173
Sex (female)0.2780.3710.56110.4541.3200.6382.729
Sex (male)−0.2780.3710.56110.4540.7580.3661.566
Risk of falls (YES)−0.4270.8360.26110.6090.6520.1273.360
Downton score0.4480.1558.38510.0041.5651.1562.120
Readmission0.9340.4993.50210.0612.5440.9576.764
Diabetes (YES)0.3570.3640.95910.3271.4290.7002.916
Chest pain (YES)0.0000.3700.00011.0001.0000.4852.064
Dyspnoea (YES)0.4800.3761.62410.2031.6150.7733.378
Barthel index−0.1030.02813.50310.0000.9020.8540.953
Oxygen saturation (SpO2)−0.1400.0733.71310.0540.8690.7541.002
Heart rate0.0010.0110.00310.9601.0010.9801.022
Systolic blood pressure0.0060.0090.38510.5351.0060.9881.024
Diastolic blood pressure−0.0370.0184.24710.0390.9630.9300.998
Blood glucose0.0010.0030.15810.6911.0010.9951.008
Length of stay0.0960.0386.31810.0121.1011.0211.186
Waist circumference0.0310.0154.35210.0371.0311.0021.062
BMI0.0610.0412.22510.1361.0630.9811.152
Table 7. Relationship between frailty status (frail–non-frail) and the Downton scale items.
Table 7. Relationship between frailty status (frail–non-frail) and the Downton scale items.
J.H. Downton Scale Itemsβ ErrorStandard ErrorWalddfpExp(β) (Odds Ratio)95% CI for Exp(β)
InferiorSuperior
Previous falls (YES)0.0000.5350.00011.0001.0000.3512.851
Medications (diuretics)1.4470.6804.52510.0334.2501.12016.120
Sensory deficit (extremities)2.0841.1783.13010.0778.0400.79980.943
Mental state (confused)21.91740,192.9690.00011.0003,299,693,296.0360.000
Gait (normal)−1.3610.4748.24910.0040.2560.1010.649
Table 8. Relationship between frailty status (frail–non-frail) and clinical diagnoses at admission.
Table 8. Relationship between frailty status (frail–non-frail) and clinical diagnoses at admission.
Diagnosesβ ErrorStandard ErrorWalddfpExp(β) (Odds Ratio)95% CI for Exp(β)
Lower limitUpper limit
Arrhythmias−1.3860.8942.40210.1210.2500.0431.443
Infectious endocarditis−0.6931.5810.19210.6610.5000.02311.088
Heart failure−1.0410.8011.68910.1940.3530.0731.698
Coronary heart disease−1.7320.7485.36810.0210.1770.0410.766
Heart transplant20.51040,192.9690.00011.000807,737,421.4260.000
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rivas-González, N.; López, M.; Martín-Gil, B.; Fernández-Castro, M.; Castro, M.J.; San Román, J.A. Relationship Between Frailty and Risk of Falls Among Hospitalised Older People with Cardiac Conditions: An Observational Cohort Study. Nurs. Rep. 2025, 15, 100. https://doi.org/10.3390/nursrep15030100

AMA Style

Rivas-González N, López M, Martín-Gil B, Fernández-Castro M, Castro MJ, San Román JA. Relationship Between Frailty and Risk of Falls Among Hospitalised Older People with Cardiac Conditions: An Observational Cohort Study. Nursing Reports. 2025; 15(3):100. https://doi.org/10.3390/nursrep15030100

Chicago/Turabian Style

Rivas-González, Noel, María López, Belén Martín-Gil, Mercedes Fernández-Castro, María José Castro, and J. Alberto San Román. 2025. "Relationship Between Frailty and Risk of Falls Among Hospitalised Older People with Cardiac Conditions: An Observational Cohort Study" Nursing Reports 15, no. 3: 100. https://doi.org/10.3390/nursrep15030100

APA Style

Rivas-González, N., López, M., Martín-Gil, B., Fernández-Castro, M., Castro, M. J., & San Román, J. A. (2025). Relationship Between Frailty and Risk of Falls Among Hospitalised Older People with Cardiac Conditions: An Observational Cohort Study. Nursing Reports, 15(3), 100. https://doi.org/10.3390/nursrep15030100

Article Metrics

Back to TopTop